Physician profile
Cara E Brown
NPI 1942399134
$4,003.70
in general payments reported to CMS, 2019-2025
39 companies · $930 in 2025
The $930 reported for 2025 was more than what 86% of Adolescent Medicine (Family Medicine) providers received nationally (typical 2025 total: $135).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $320 · 2021: $574 · 2022: $175 · 2023: $659 · 2024: $784 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,374.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $383.30 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $348.48 | 2019-2025 | Arexvy, Shingrix, Bexsero |
| Lilly USA, LLC | $316.76 | 2019-2025 | Mounjaro, Zepbound |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $290.36 | 2023-2025 | Caplyta |
| Amgen INC. | $270.53 | 2019-2024 | Otezla, Repatha, Prolia |
| Abbvie INC. | $259.41 | 2021-2025 | Vraylar, Ubrelvy |
| Pfizer INC. | $222.62 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $220.72 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Adlon Therapeutics L.P. | $200.76 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.26 | 2019-2023 | Jardiance |
| Novo Nordisk INC | $138.73 | 2021-2025 | Wegovy, Ozempic |
| Merck Sharp & Dohme LLC | $133.48 | 2019-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Novartis Pharmaceuticals Corporation | $119.09 | 2024-2025 | |
| Biohaven Pharmaceuticals, INC. | $91.76 | 2021 | |
| Exact Sciences Corporation | $87.03 | 2023-2024 | Cologuard Collection Kit |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.